8-31096778-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_000553.6(WRN):c.1909C>T(p.Arg637Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,609,108 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000553.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WRN | ENST00000298139.7 | c.1909C>T | p.Arg637Trp | missense_variant | Exon 17 of 35 | 1 | NM_000553.6 | ENSP00000298139.5 | ||
WRN | ENST00000521620.5 | n.542C>T | non_coding_transcript_exon_variant | Exon 5 of 23 | 1 | |||||
WRN | ENST00000650667.1 | n.*1523C>T | non_coding_transcript_exon_variant | Exon 16 of 34 | ENSP00000498593.1 | |||||
WRN | ENST00000650667.1 | n.*1523C>T | 3_prime_UTR_variant | Exon 16 of 34 | ENSP00000498593.1 |
Frequencies
GnomAD3 genomes AF: 0.000321 AC: 48AN: 149736Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000412 AC: 103AN: 249788Hom.: 0 AF XY: 0.000392 AC XY: 53AN XY: 135134
GnomAD4 exome AF: 0.000372 AC: 543AN: 1459272Hom.: 1 Cov.: 33 AF XY: 0.000373 AC XY: 271AN XY: 726072
GnomAD4 genome AF: 0.000327 AC: 49AN: 149836Hom.: 0 Cov.: 31 AF XY: 0.000316 AC XY: 23AN XY: 72888
ClinVar
Submissions by phenotype
not provided Uncertain:2
The WRN p.Arg637Trp variant was identified in 1 of 18 Werner syndrome patients; the variant was identified as a compound heterozygous mutation in a male with Werner syndrome, osteoporosis and cancer (Uhrhammer_2006_PMID:16786514). The variant was identified in dbSNP (ID: rs148286708) and ClinVar (classified as uncertain significance by EGL Genetic Diagnotics and Invitae) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 111 of 279850 chromosomes (0 homozygous) at a frequency of 0.0003966 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 7 of 10332 chromosomes (freq: 0.000678), European (non-Finnish) in 79 of 128100 chromosomes (freq: 0.000617), Other in 4 of 7152 chromosomes (freq: 0.000559), Latino in 17 of 35294 chromosomes (freq: 0.000482), South Asian in 3 of 30544 chromosomes (freq: 0.000098) and European (Finnish) in 1 of 23934 chromosomes (freq: 0.000042), but was not observed in the African or East Asian populations. The p.Arg637 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
Werner syndrome Uncertain:1Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
not specified Uncertain:1Other:1
DNA sequence analysis of the WRN gene demonstrated a sequence change, c.1909C>T, in exon 17 that results in an amino acid change, p.Arg637Trp. This sequence change has been described in gnomAD with a frequency of 0.062% in Non-Finnish European sub-population (dbSNP rs148286708). The p.Arg637Trp change affects a highly conserved amino acid residue located in a domain of the WRN protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg637Trp substitution. This particular sequence change has been reported in the compound heterozygous state in one individual with Werner syndrome, osteoporosis, and cancer (PMID: 16786514). Due to the lack of sufficient evidences, the clinical significance of the p.Arg637Trp change remains unknown at this time. -
- -
WRN-related disorder Uncertain:1
The WRN c.1909C>T variant is predicted to result in the amino acid substitution p.Arg637Trp. This variant was reported in the compound heterozygous state in an individual with Werner syndrome; however no functional or family segregation studies have confirmed its pathogenicity (Patient 943-1, Uhrhammer et al. 2006. PubMed ID: 16786514). This variant was also reported in an individual with head and neck cancer (Table S3, Cury et al. 2021. PubMed ID: 34598035) and an individual with osteosarcoma (eTable 5, Mirabello et al. 2020. PubMed ID: 32191290). This variant is reported in 0.068% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. In ClinVar, this variant has conflicting interpretations of pathogenicity ranging from benign to uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/135421). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at